{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:53:04Z","timestamp":1791262384393,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008731","name":"European Leukodystrophies Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.09.019","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:45:27Z","timestamp":1789800327000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease"],"prefix":"10.1016","author":[{"given":"Anne E.J.","family":"Hillen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Norata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Mombled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Laface","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Zambonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5807-7827","authenticated-orcid":false,"given":"Andrea","family":"Lomagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Rouillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-7793","authenticated-orcid":false,"given":"Serena G.","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4626-1386","authenticated-orcid":false,"given":"Francesco","family":"Gazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Spinozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanvito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Amendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Broccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Montini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gritti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-6495","authenticated-orcid":false,"given":"Vasco","family":"Meneghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.09.019_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cns.13123","article-title":"Astrocyte morphology: Diversity, plasticity, and role in neurological diseases","volume":"25","author":"Zhou","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.expneurol.2016.03.009","article-title":"The multifaceted role of astrocytes in regulating myelination","volume":"283","author":"K\u0131ray","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.nurt.2010.07.006","article-title":"Functions of Astrocytes and their Potential As Therapeutic Targets","volume":"7","author":"Kimelberg","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2026.09.019_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.molmed.2019.04.010","article-title":"Astrocytes: Emerging Therapeutic Targets in Neurological Disorders","volume":"25","author":"Valori","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib6","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1523\/JNEUROSCI.5384-11.2012","article-title":"Alexander Disease","volume":"32","author":"Messing","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.019_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","article-title":"Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system","volume":"32","author":"Hol","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nurt.2010.05.013","article-title":"Strategies for Treatment in Alexander Disease","volume":"7","author":"Messing","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymthe.2026.09.019_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2025.109689","article-title":"Genotype-phenotype correlations of GFAP variants in type I Alexander disease subtypes","volume":"147","author":"Bachetti","year":"2026","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.09.019_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/nmt-2020-0022","article-title":"Clinical characteristics of Alexander disease","volume":"10","author":"Yoshida","year":"2020","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.ymthe.2026.09.019_bib11","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1021\/acs.jproteome.6b00316","article-title":"Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease","volume":"15","author":"Heaven","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ymthe.2026.09.019_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s11689-019-9290-0","article-title":"Refining the concept of GFAP toxicity in Alexander disease","volume":"11","author":"Messing","year":"2019","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.ymthe.2026.09.019_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0080-15.2015","article-title":"CSF and blood levels of GFAP in Alexander disease","volume":"2","author":"Jany","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.ymthe.2026.09.019_bib14","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1007\/s10072-024-07495-8","article-title":"Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease","volume":"45","author":"Ashton","year":"2024","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymthe.2026.09.019_bib15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/acn3.70305","article-title":"Characterization of Clinical Phenotype to Glial Fibrillary Acidic Protein Concentrations in Alexander Disease","volume":"13","author":"Waldman","year":"2026","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.conb.2021.10.002","article-title":"Alexander disease: models, mechanisms, and medicine","volume":"72","author":"Hagemann","year":"2022","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100180","article-title":"Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis","volume":"21","author":"Heaven","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ymthe.2026.09.019_bib18","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1523\/JNEUROSCI.1659-21.2021","article-title":"Anastasis Drives Senescence and Non-Cell Autonomous Neurodegeneration in the Astrogliopathy Alexander Disease","volume":"42","author":"Wang","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.019_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103544","article-title":"A multi-omics approach reveals impaired lipid metabolism and oxidative stress in a zebrafish model of Alexander disease","volume":"81","author":"Bellitto","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102415","article-title":"Alexander disease GFAP R239C mutant shows increased susceptibility to lipoxidation and elicits mitochondrial dysfunction and oxidative stress","volume":"55","author":"Viedma-Poyatos","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037304","article-title":"Genetic ablation of Nrf2\/antioxidant response pathway in alexander disease mice reduces hippocampal gliosis but does not impact survival","volume":"7","author":"Hagemann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.09.019_bib22","doi-asserted-by":"crossref","first-page":"8966","DOI":"10.1038\/ncomms9966","article-title":"Nitric oxide mediates glial-induced neurodegeneration in Alexander disease","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.019_bib23","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3389\/fimmu.2020.01416","article-title":"Crosstalk Between Astrocytes and Microglia: An Overview","volume":"11","author":"Matejuk","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi7828","article-title":"Neuroinflammation: An astrocyte perspective","volume":"15","author":"Lee","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2018.07.009","article-title":"GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.09.019_bib26","first-page":"541","article-title":"Alexander disease: Diagnosis with MR imaging","volume":"22","author":"Van der Knaap","year":"2001","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib27","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00415-011-6056-3","article-title":"Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis","volume":"258","author":"Yoshida","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107540","article-title":"Type I Alexander disease: Update and validation of the clinical evolution-based classification","volume":"138","author":"Vaia","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.09.019_bib29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0b013e3182309f72","article-title":"GFAP mutations, age at onset, and clinical subtypes in Alexander disease","volume":"77","author":"Prust","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2026.09.019_bib30","doi-asserted-by":"crossref","first-page":"24341","DOI":"10.1038\/s41598-024-75383-4","article-title":"A systematic review and meta-analysis of GFAP gene variants in Alexander disease","volume":"14","author":"Grossi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.09.019_bib31","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200296","article-title":"Genotype-Phenotype Association for 14 GFAP Variants in Alexander Disease","volume":"11","author":"Messing","year":"2025","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.019_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ana.25118","article-title":"Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease","volume":"83","author":"Hagemann","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg4711","article-title":"Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment","volume":"13","author":"Hagemann","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420949680","article-title":"GFAP at 50","volume":"12","author":"Messing","year":"2020","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ymthe.2026.09.019_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2014.01.055","article-title":"Role of GFAP in CNS injuries","volume":"565","author":"Brenner","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymthe.2026.09.019_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3721","article-title":"Gene therapy clinical trials worldwide to 2023-an update","volume":"26","author":"Ginn","year":"2024","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib38","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene Editing for CEP290 -Associated Retinal Degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib39","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41434-021-00223-3","article-title":"Use of CRISPR\/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice","volume":"28","author":"Torregrosa","year":"2021","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR\u2013Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.019_bib41","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","article-title":"CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington\u2019s Disease Mouse Model","volume":"17","author":"Ekman","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2026.09.019_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/cells13100800","article-title":"CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments","volume":"13","author":"Laurent","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2026.09.019_bib43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.cell.2015.08.007","article-title":"Crystal Structure of Staphylococcus aureus Cas9","volume":"162","author":"Nishimasu","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.09.019_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.09.019_bib45","article-title":"Delivery Platforms for CRISPR\/Cas9 Genome Editing of Glial Cells in the Central Nervous System","volume":"3","author":"Meneghini","year":"2021","journal-title":"Front. Genome"},{"key":"10.1016\/j.ymthe.2026.09.019_bib46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2026.09.019_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ymthe.2023.01.004","article-title":"Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain","volume":"31","author":"Simpson","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib49","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.019_bib50","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1016\/j.ymthe.2024.09.032","article-title":"AAV vector-derived elements integrate into Cas9-generated double-strand breaks and disrupt gene transcription","volume":"32","author":"Bazick","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib51","doi-asserted-by":"crossref","first-page":"11162","DOI":"10.1523\/JNEUROSCI.3260-06.2006","article-title":"Alexander Disease-Associated Glial Fibrillary Acidic Protein Mutations in Mice Induce Rosenthal Fiber Formation and a White Matter Stress Response","volume":"26","author":"Hagemann","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.019_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2026.09.019_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-015-1469-1","article-title":"Astrocyte pathology in Alexander disease causes a marked inflammatory environment","volume":"130","author":"Olabarria","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib54","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/bpa.12601","article-title":"Alexander disease: an astrocytopathy that produces a leukodystrophy","volume":"28","author":"Sosunov","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188830","article-title":"Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection","volume":"12","author":"Hammond","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.09.019_bib56","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3389\/fnhum.2016.00566","article-title":"The indispensable roles of microglia and astrocytes during brain development","volume":"10","author":"Reemst","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.ymthe.2026.09.019_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/glia.20622","article-title":"GFAP promoter elements required for region-specific and astrocyte-specific expression","volume":"56","author":"Lee","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.ymthe.2026.09.019_bib58","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12974-021-02118-x","article-title":"Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes","volume":"18","author":"Boyd","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ymthe.2026.09.019_bib60","first-page":"2316","article-title":"Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci","volume":"141","author":"Calabria","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2026.09.019_bib61","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.stem.2022.09.001","article-title":"Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells","volume":"29","author":"Ferrari","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2026.09.019_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101494","article-title":"Common AAV gene therapy vectors show nonselective transduction of ex vivo human brain tissue","volume":"33","author":"McGinnis","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.09.019_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067680","article-title":"Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain","volume":"8","author":"Chakrabarty","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.09.019_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2023.1130729","article-title":"Human and mouse cortical astrocytes: a comparative view from development to morphological and functional characterization","volume":"17","author":"Degl\u2019Innocenti","year":"2023","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ymthe.2026.09.019_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101357","article-title":"Advances in AAV-mediated gene replacement therapy for pediatric monogenic neurological disorders","volume":"32","author":"Zhou","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.09.019_bib66","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ymthe.2019.06.015","article-title":"Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease","volume":"27","author":"Cain","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/hum.2020.301","article-title":"Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System","volume":"32","author":"Galvan","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2026.09.019_bib68","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41551-022-00911-4","article-title":"Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors","volume":"6","author":"Davis","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.ymthe.2026.09.019_bib69","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1038\/s41467-023-42746-w","article-title":"A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences","volume":"14","author":"Gleichman","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.019_bib70","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/hmg\/ddu034","article-title":"Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy","volume":"23","author":"Lattanzi","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2026.09.019_bib71","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1074\/jbc.M116.772020","article-title":"Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of alexander disease","volume":"292","author":"Moody","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.019_bib72","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1073\/pnas.93.13.6361","article-title":"Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology","volume":"93","author":"McCall","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.019_bib73","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00004647-200007000-00003","article-title":"High Susceptibility to Cerebral Ischemia in GFAP-Null Mice","volume":"20","author":"Nawashiro","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ymthe.2026.09.019_bib74","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/00001756-199806010-00004","article-title":"Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury","volume":"9","author":"Nawashiro","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ymthe.2026.09.019_bib75","first-page":"391","article-title":"Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice","volume":"152","author":"Messing","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib76","doi-asserted-by":"crossref","first-page":"38634","DOI":"10.1074\/jbc.M604942200","article-title":"Synergistic effects of the SAPK\/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease","volume":"281","author":"Tang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.09.019_bib77","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1073\/pnas.1218497110","article-title":"Reactive astrocytes secrete lcn2 to promote neuron death","volume":"110","author":"Bi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.09.019_bib78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41589-023-01427-x","article-title":"Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibility","volume":"20","author":"Schmidheini","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib79","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/genbio.2022.0015","article-title":"Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector","volume":"1","author":"Zhang","year":"2022","journal-title":"GEN. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib80","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1038\/s41467-020-18715-y","article-title":"Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing","volume":"11","author":"Nguyen Tran","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.019_bib81","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1038\/s41467-024-47800-9","article-title":"CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing","volume":"15","author":"Pedrazzoli","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.09.019_bib82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-024-03215-9","article-title":"Eukaryotic-driven directed evolution of Cas9 nucleases","volume":"25","author":"Ruta","year":"2024","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib83","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/crispr.2021.0143","article-title":"Compact Cje3Cas9 for Efficient in Vivo Genome Editing and Adenine Base Editing","volume":"5","author":"Chen","year":"2022","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2026.09.019_bib84","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa2405727","article-title":"Long-Term Effects of Atidarsagene Autotemcel for Metachromatic Leukodystrophy","volume":"392","author":"Fumagalli","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib85","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ymgme.2021.11.009","article-title":"Alexander disease evolution over time: data from an Italian cohort of pediatric-onset patients","volume":"134","author":"Mura","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2026.09.019_bib86","article-title":"Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction","volume":"15","author":"Kim","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ymthe.2026.09.019_bib87","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1078\/0940-2993-00350","article-title":"Revised guides for organ sampling and trimming in rats and mice \u2013 Part 3. A joint publication of the RITA and NACAD groups","volume":"55","author":"Morawietz","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2026.09.019_bib88","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41591-021-01389-4","article-title":"Retrieval of vector integration sites from cell-free DNA","volume":"27","author":"Cesana","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.09.019_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gnh172","article-title":"Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h","volume":"32","author":"Chiu","year":"2004","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:19:56Z","timestamp":1791260396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":89,"alternative-id":["S1525001626007896"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}